Workflow
深圳市卫光生物制品股份有限公司 关于2025年度向特定对象发行A股股票申请获得深圳证券交易所受理的 公告

Core Points - Shenzhen Wego Biological Products Co., Ltd. has received acceptance from the Shenzhen Stock Exchange for its application to issue A-shares to specific investors [1] - The application documents submitted by the company were found to be complete and were accepted by the Shenzhen Stock Exchange [1] - The issuance of A-shares is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, indicating uncertainty in the final approval process [1] Summary by Sections - Company Announcement - The company announced on October 10, 2025, that it received a notification from the Shenzhen Stock Exchange regarding the acceptance of its application for a specific issuance of A-shares [1] - The board of directors ensures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - Regulatory Process - The acceptance of the application is a preliminary step, and the final decision depends on further review and approval by the Shenzhen Stock Exchange and the China Securities Regulatory Commission [1] - The company will continue to fulfill its information disclosure obligations based on the progress of this matter [1]